Understanding how a specific tRNA modification affects brain function and disorders
Mechanism and functions of DALRD3-dependent tRNA modification
This study is looking at how a special enzyme called DALRD3 affects a type of molecule important for making proteins in the brain, and it's especially focused on understanding how changes in this enzyme might be linked to certain brain disorders like epileptic encephalopathy, so we can learn more about what causes these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10895444 on NIH RePORTER |
What this research studies
This research investigates the role of a specific enzyme, DALRD3, in modifying tRNA, which is crucial for protein synthesis in the brain. The study aims to uncover how genetic variants in tRNA modification enzymes contribute to neurological disorders, particularly focusing on a variant linked to epileptic encephalopathy. By examining the molecular and cellular functions of DALRD3, the researchers hope to clarify its impact on tRNA stability and function during neurodevelopment. This could lead to a better understanding of the mechanisms behind brain disorders associated with tRNA modifications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic variants affecting tRNA modification enzymes, particularly those experiencing neurological disorders such as epileptic encephalopathy.
Not a fit: Patients with neurological disorders not linked to tRNA modification or those without genetic variants in relevant enzymes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights and potential treatments for neurodevelopmental and neurological disorders linked to tRNA modifications.
How similar studies have performed: While the specific focus on DALRD3 is novel, previous research has shown that understanding tRNA modifications can lead to breakthroughs in treating related neurological conditions.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Fu, Dragony — University of Rochester
- Study coordinator: Fu, Dragony
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.